Call Our Free Legal Helpline Anytime
(800) 884-9402 or tell us about your case

Risperdal Lawsuit Information

19 January 2014

Johnson & Johnson to make arguments in appeal of $1.2 billion Risperdal fine on Feb 27

On February 27, 2014, the Arkansas Supreme Court will hear arguments from Risperdal manufacturer Johnson & Johnson (parent company of Risperdal maker, Janssen Pharmaceuticals), which is appealing a $1.2 billion fine that was handed down in 2012.

The fine was issued after evidence came forward, supporting allegations that Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, allegedly downplayed the health risks that have been associated with Risperdal.

Notably, this isn’t the only Risperdal-related fine that Johnson & Johnson has faced in recent months. It was also alleged that the Risperdal manufacturer promoted off-label, non-approved uses of the drug in the treatment of children with ADHD. In that case, which fell under the U.S. False Claims Act, Johnson & Johnson agreed to pay a $2.2 billion penalty.

Risperdal is an atypical antipsychotic drug that’s used to treat schizophrenia, bipolar disorder, dementia and autism, among other conditions. It’s administered in children, teens and adults.

Risperdal manufacturer Johnson & Johnson is also facing a slew of personal injury lawsuits. The drug maker has come under fire in recent months due to the serious side effects that many patients have suffered, including gynecomastia — a condition whereby males develop female-like breasts.

Gynecomastia is a serous condition not only causes serious mental distress and social problems; some males were forced to undergo medical treatments and even surgery to reverse the condition. Young males, teens and adult males have reportedly suffered from gynecomastia.

A handful of elderly patients who were treated with Risperdal in an attempt to relieve dementia- associated agitation, reportedly experienced sudden death as a result of taking the drug.

Other Risperdal side effects include tardive dyskinesia, dystonia, breast tenderness and discharge, diabetes-related complications stemming from high blood sugar levels, heart failure and the development of pituitary tumors. Some females also experienced lactation while taking Risperdal.

These serious and potentially lethal side effects have led dozens of patients to file personal injury lawsuits against Risperdal’s maker. The first batch of trials are scheduled to move forward for trial in early June 2014.

If you’ve suffered side effects while taking Risperdal, you’re encouraged to contact The Ledger Law Firm. We’re now representing clients who have suffered pain, suffering and incurred medical bills and other damages as a result of taking Risperdal. To discuss your case with one of our compassionate patient advocates, call (800) 884-9402.